Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.05
NAS:MMSI's Cash to Debt is ranked lower than
95% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. NAS:MMSI: 0.05 )
Ranked among companies with meaningful Cash to Debt only.
NAS:MMSI' s Cash to Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.13 Max: No Debt
Current: 0.05
Equity to Asset 0.52
NAS:MMSI's Equity to Asset is ranked lower than
63% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. NAS:MMSI: 0.52 )
Ranked among companies with meaningful Equity to Asset only.
NAS:MMSI' s Equity to Asset Range Over the Past 10 Years
Min: 0.44  Med: 0.72 Max: 0.84
Current: 0.52
0.44
0.84
Interest Coverage 4.00
NAS:MMSI's Interest Coverage is ranked lower than
86% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 35.09 vs. NAS:MMSI: 4.00 )
Ranked among companies with meaningful Interest Coverage only.
NAS:MMSI' s Interest Coverage Range Over the Past 10 Years
Min: 3.46  Med: 45.57 Max: 7656.67
Current: 4
3.46
7656.67
F-Score: 5
Z-Score: 2.83
M-Score: -2.51
WACC vs ROIC
8.58%
-79.30%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 5.19
NAS:MMSI's Operating margin (%) is ranked higher than
52% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. NAS:MMSI: 5.19 )
Ranked among companies with meaningful Operating margin (%) only.
NAS:MMSI' s Operating margin (%) Range Over the Past 10 Years
Min: 5.19  Med: 8.56 Max: 13.64
Current: 5.19
5.19
13.64
Net-margin (%) 3.25
NAS:MMSI's Net-margin (%) is ranked higher than
53% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. NAS:MMSI: 3.25 )
Ranked among companies with meaningful Net-margin (%) only.
NAS:MMSI' s Net-margin (%) Range Over the Past 10 Years
Min: 3.25  Med: 5.71 Max: 9.13
Current: 3.25
3.25
9.13
ROE (%) 4.03
NAS:MMSI's ROE (%) is ranked higher than
51% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.51 vs. NAS:MMSI: 4.03 )
Ranked among companies with meaningful ROE (%) only.
NAS:MMSI' s ROE (%) Range Over the Past 10 Years
Min: 4.03  Med: 6.63 Max: 11.56
Current: 4.03
4.03
11.56
ROA (%) 2.32
NAS:MMSI's ROA (%) is ranked higher than
55% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. NAS:MMSI: 2.32 )
Ranked among companies with meaningful ROA (%) only.
NAS:MMSI' s ROA (%) Range Over the Past 10 Years
Min: 2.31  Med: 4.77 Max: 9.59
Current: 2.32
2.31
9.59
ROC (Joel Greenblatt) (%) 7.48
NAS:MMSI's ROC (Joel Greenblatt) (%) is ranked lower than
53% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.00 vs. NAS:MMSI: 7.48 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NAS:MMSI' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 7.48  Med: 13.01 Max: 21.49
Current: 7.48
7.48
21.49
Revenue Growth (3Y)(%) 9.60
NAS:MMSI's Revenue Growth (3Y)(%) is ranked higher than
73% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. NAS:MMSI: 9.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NAS:MMSI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0.9  Med: 10 Max: 18.6
Current: 9.6
0.9
18.6
EBITDA Growth (3Y)(%) 12.20
NAS:MMSI's EBITDA Growth (3Y)(%) is ranked higher than
66% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. NAS:MMSI: 12.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NAS:MMSI' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -9.1  Med: 9.9 Max: 50.4
Current: 12.2
-9.1
50.4
EPS Growth (3Y)(%) 4.80
NAS:MMSI's EPS Growth (3Y)(%) is ranked lower than
52% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. NAS:MMSI: 4.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NAS:MMSI' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -16.5  Med: 4.8 Max: 160.4
Current: 4.8
-16.5
160.4
» NAS:MMSI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

MMSI Guru Trades in Q4 2015

Ken Fisher 170,987 sh (+15.72%)
Joel Greenblatt Sold Out
Jim Simons 527,900 sh (-5.07%)
Paul Tudor Jones 31,745 sh (-7.11%)
Chuck Royce 806,009 sh (-17.65%)
» More
Q1 2016

MMSI Guru Trades in Q1 2016

Ken Fisher 185,797 sh (+8.66%)
Paul Tudor Jones Sold Out
Jim Simons 486,900 sh (-7.77%)
Chuck Royce 627,786 sh (-22.11%)
» More
Q2 2016

MMSI Guru Trades in Q2 2016

Paul Tudor Jones 12,139 sh (New)
Ken Fisher 185,797 sh (unchged)
Chuck Royce 627,786 sh (unchged)
Jim Simons 362,200 sh (-25.61%)
» More
Q3 2016

MMSI Guru Trades in Q3 2016

Steven Cohen 224,600 sh (New)
Chuck Royce 627,786 sh (unchged)
Paul Tudor Jones 11,714 sh (-3.50%)
Ken Fisher 145,380 sh (-21.75%)
Jim Simons 276,900 sh (-23.55%)
» More
» Details

Insider Trades

Latest Guru Trades with MMSI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NYSE:GKOS, NAS:LMNX, NAS:ATRI, NAS:NVCR, OTCPK:NNCSF, NAS:ATRC, NAS:ELGX, NAS:ANGO, OTCPK:TOPCF, NAS:OSUR, NAS:MLAB, NAS:NXTM, AMEX:CRHM, NAS:LMAT, NAS:STAA, NYSE:HYH, NAS:CFMS, OTCPK:GMDTF, NAS:ENTL, NAS:ATRS » details
Traded in other countries:MM3.Germany,
Merit Medical Systems Inc designs, develops, manufactures and sells medical devices used in interventional and diagnostic procedures. Its products are used in thoracic surgery, interventional nephrology, vascular surgery, and oncology and pain management.

Merit Medical Systems Inc was organized in July 1987 as a Utah corporation. The Company designs, develops, manufactures and sells medical devices used in interventional and diagnostic procedures. It provides its products to physicians and healthcare professionals to enhance patient care and enable them to perform procedures safely and effectively. Its operations are divided into the following principal markets: diagnostic and interventional cardiology, interventional radiology, interventional gastroenterology, interventional pulmonology, vascular surgery, interventional nephrology, and thoracic surgery. Its devices include Rad Board, Rad Board Xtra, Rad Trac and Rad Rest, which are used for patient positioning during radial access procedures; Safeguard Pressure Assisted Device, which assists in obtaining and maintaining hemostasis after a femoral procedure, and the Air-Band Radial Compression Device, which is indicated to assist hemostasis of the radial artery puncture site while maintaining visibility. The Company's products are also used in other clinical areas such as thoracic surgery, interventional nephrology, vascular surgery, and oncology and pain management. The Company offers safety-related products and kits. Its ShortStop and ShortStop Advantage Temporary Sharps Holders address the potential safety issues associated with accidental needle sticks. Its extensive line of color-coded Medallion Syringes and the PAL Pen and Label Medication Labeling System comply with patient safety initiatives of The Joint Commission and are designed to help minimize mix-ups in administering medication. It also offers waste management products to help avoid accidental exposure to contaminated fluids such as Occupational Safety and Health Administration compliant waste disposal basins: the BackStop, BackStop+, MiniStop, MiniStop+, and DugOut. The Company offer devices used to gain and maintain vascular access while protecting the clinician from accidental cuts and needle sticks during procedures such as the Futura Safety Scalpel and angiography needles such as the Merit Advance and the SecureLoc Safety Introducer Needle. It also offers sheath introducers such as Prelude and mini access kits such as MAK and S-MAK, designed to provide clinicians with smooth, less traumatic, and convenient access to the patient's vasculature. The Company offers the Clo-Sur PLUS P.A.D, intended for the local management of bleeding wounds and the creation of a barrier to bacterial penetration. It also offers two independent, differentiated radial compression systems, the Finale Compression Device and the RADStat Radial Artery Compression Device. Its diagnostic guide wires are used to traverse vascular anatomy and aid in placing catheters and other devices such as the pre-coated InQwire Diagnostic Guide Wires. The Merit Laureate Hydrophilic Guide Wire promotes rapid catheter exchanges and minimizes friction. It also offers the BowTie Guide Wire Insertion Device, us

Ratios

vs
industry
vs
history
P/E(ttm) 58.58
MMSI's P/E(ttm) is ranked lower than
84% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.70 vs. MMSI: 58.58 )
Ranked among companies with meaningful P/E(ttm) only.
MMSI' s P/E(ttm) Range Over the Past 10 Years
Min: 12.91  Med: 28.7 Max: 66.08
Current: 58.58
12.91
66.08
Forward P/E 21.60
MMSI's Forward P/E is ranked higher than
58% of the 36 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.22 vs. MMSI: 21.60 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 58.58
MMSI's PE(NRI) is ranked lower than
84% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.99 vs. MMSI: 58.58 )
Ranked among companies with meaningful PE(NRI) only.
MMSI' s PE(NRI) Range Over the Past 10 Years
Min: 13.03  Med: 28.75 Max: 66.08
Current: 58.58
13.03
66.08
Price/Owner Earnings (ttm) 1447.10
MMSI's Price/Owner Earnings (ttm) is ranked lower than
100% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.96 vs. MMSI: 1447.10 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
MMSI' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 22.45  Med: 58.74 Max: 2796
Current: 1447.1
22.45
2796
P/B 2.29
MMSI's P/B is ranked higher than
62% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.12 vs. MMSI: 2.29 )
Ranked among companies with meaningful P/B only.
MMSI' s P/B Range Over the Past 10 Years
Min: 1.08  Med: 1.98 Max: 3.2
Current: 2.29
1.08
3.2
P/S 1.93
MMSI's P/S is ranked higher than
66% of the 222 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.98 vs. MMSI: 1.93 )
Ranked among companies with meaningful P/S only.
MMSI' s P/S Range Over the Past 10 Years
Min: 1.03  Med: 1.62 Max: 2.69
Current: 1.93
1.03
2.69
PFCF 126.82
MMSI's PFCF is ranked lower than
90% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.87 vs. MMSI: 126.82 )
Ranked among companies with meaningful PFCF only.
MMSI' s PFCF Range Over the Past 10 Years
Min: 21.84  Med: 44.97 Max: 188.41
Current: 126.82
21.84
188.41
POCF 22.50
MMSI's POCF is ranked lower than
62% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.05 vs. MMSI: 22.50 )
Ranked among companies with meaningful POCF only.
MMSI' s POCF Range Over the Past 10 Years
Min: 9.2  Med: 14.6 Max: 37.43
Current: 22.5
9.2
37.43
EV-to-EBIT 47.14
MMSI's EV-to-EBIT is ranked lower than
81% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.14 vs. MMSI: 47.14 )
Ranked among companies with meaningful EV-to-EBIT only.
MMSI' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.1  Med: 21.15 Max: 49.9
Current: 47.14
8.1
49.9
EV-to-EBITDA 19.79
MMSI's EV-to-EBITDA is ranked lower than
61% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.65 vs. MMSI: 19.79 )
Ranked among companies with meaningful EV-to-EBITDA only.
MMSI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.1  Med: 12.8 Max: 20.5
Current: 19.79
6.1
20.5
PEG 4.60
MMSI's PEG is ranked lower than
69% of the 62 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.68 vs. MMSI: 4.60 )
Ranked among companies with meaningful PEG only.
MMSI' s PEG Range Over the Past 10 Years
Min: 0.81  Med: 4.37 Max: 96.23
Current: 4.6
0.81
96.23
Shiller P/E 46.00
MMSI's Shiller P/E is ranked lower than
55% of the 47 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 39.92 vs. MMSI: 46.00 )
Ranked among companies with meaningful Shiller P/E only.
MMSI' s Shiller P/E Range Over the Past 10 Years
Min: 18.07  Med: 29.71 Max: 48.23
Current: 46
18.07
48.23
Current Ratio 2.71
MMSI's Current Ratio is ranked higher than
57% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. MMSI: 2.71 )
Ranked among companies with meaningful Current Ratio only.
MMSI' s Current Ratio Range Over the Past 10 Years
Min: 1.84  Med: 3 Max: 5.18
Current: 2.71
1.84
5.18
Quick Ratio 1.36
MMSI's Quick Ratio is ranked lower than
61% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. MMSI: 1.36 )
Ranked among companies with meaningful Quick Ratio only.
MMSI' s Quick Ratio Range Over the Past 10 Years
Min: 0.78  Med: 1.43 Max: 3.56
Current: 1.36
0.78
3.56
Days Inventory 120.50
MMSI's Days Inventory is ranked higher than
52% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 123.20 vs. MMSI: 120.50 )
Ranked among companies with meaningful Days Inventory only.
MMSI' s Days Inventory Range Over the Past 10 Years
Min: 98.79  Med: 114.31 Max: 132.82
Current: 120.5
98.79
132.82
Days Sales Outstanding 49.77
MMSI's Days Sales Outstanding is ranked higher than
74% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.14 vs. MMSI: 49.77 )
Ranked among companies with meaningful Days Sales Outstanding only.
MMSI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 41.18  Med: 47.04 Max: 52.07
Current: 49.77
41.18
52.07
Days Payable 33.45
MMSI's Days Payable is ranked lower than
74% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.76 vs. MMSI: 33.45 )
Ranked among companies with meaningful Days Payable only.
MMSI' s Days Payable Range Over the Past 10 Years
Min: 28.96  Med: 38.12 Max: 59.55
Current: 33.45
28.96
59.55

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.40
MMSI's 3-Year Average Share Buyback Ratio is ranked higher than
60% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.10 vs. MMSI: -1.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MMSI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -6.5  Med: -3 Max: -0.6
Current: -1.4
-6.5
-0.6

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 12.62
MMSI's Price/Tangible Book is ranked lower than
90% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.38 vs. MMSI: 12.62 )
Ranked among companies with meaningful Price/Tangible Book only.
MMSI' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.35  Med: 3.13 Max: 12.74
Current: 12.62
1.35
12.74
Price/Projected FCF 2.97
MMSI's Price/Projected FCF is ranked lower than
63% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.04 vs. MMSI: 2.97 )
Ranked among companies with meaningful Price/Projected FCF only.
MMSI' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.55  Med: 2.39 Max: 19.44
Current: 2.97
1.55
19.44
Price/DCF (Earnings Based) 5.48
MMSI's Price/DCF (Earnings Based) is ranked lower than
100% of the 17 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.91 vs. MMSI: 5.48 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.16
MMSI's Price/Median PS Value is ranked lower than
54% of the 202 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.08 vs. MMSI: 1.16 )
Ranked among companies with meaningful Price/Median PS Value only.
MMSI' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.3  Med: 0.99 Max: 2.72
Current: 1.16
0.3
2.72
Price/Peter Lynch Fair Value 6.53
MMSI's Price/Peter Lynch Fair Value is ranked lower than
95% of the 39 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. MMSI: 6.53 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MMSI' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.75  Med: 2.46 Max: 13.5
Current: 6.53
0.75
13.5
Price/Graham Number 5.73
MMSI's Price/Graham Number is ranked lower than
83% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.50 vs. MMSI: 5.73 )
Ranked among companies with meaningful Price/Graham Number only.
MMSI' s Price/Graham Number Range Over the Past 10 Years
Min: 0.88  Med: 1.99 Max: 5.79
Current: 5.73
0.88
5.79
Earnings Yield (Greenblatt) (%) 2.01
MMSI's Earnings Yield (Greenblatt) (%) is ranked higher than
51% of the 228 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. MMSI: 2.01 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MMSI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2  Med: 4.7 Max: 12.4
Current: 2.01
2
12.4
Forward Rate of Return (Yacktman) (%) 8.85
MMSI's Forward Rate of Return (Yacktman) (%) is ranked lower than
53% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.02 vs. MMSI: 8.85 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MMSI' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -2.5  Med: 7.5 Max: 27.1
Current: 8.85
-2.5
27.1

More Statistics

Revenue (TTM) (Mil) $584.5
EPS (TTM) $ 0.42
Beta1.00
Short Percentage of Float3.55%
52-Week Range $15.47 - 25.10
Shares Outstanding (Mil)44.59

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 605 670 719
EPS ($) 0.94 1.12 1.29
EPS w/o NRI ($) 0.94 1.12 1.29
EPS Growth Rate
(3Y to 5Y Estimate)
15.00%
Dividends Per Share ($)
» More Articles for NAS:MMSI

Headlines

Articles On GuruFocus.com
Merit Medical Systems Inc. (MMSI) CFO Kent W Stanger sells 15,870 Shares Feb 11 2011 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Dec 16 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Nov 17 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Oct 18 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Sep 16 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Aug 18 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Jul 19 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Jun 17 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares May 21 2010 
Merit Medical Systems Inc. (MMSI) COO Arlin D Nelson sells 8,335 Shares Sep 25 2009 

More From Other Websites
ETFs with exposure to Merit Medical Systems, Inc. : November 22, 2016 Nov 22 2016
Merit Medical Systems, Inc. breached its 50 day moving average in a Bullish Manner : MMSI-US :... Nov 21 2016
MERIT MEDICAL SYSTEMS INC Financials Nov 17 2016
MERIT MEDICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report Nov 09 2016
Merit Medical Receives 510(k) Clearance for the SwiftNINJA™ Steerable Microcatheter Nov 07 2016
Merit Medical Receives 510(k) Clearance for the SwiftNINJA™ Steerable Microcatheter Nov 07 2016
ETF’s with exposure to Merit Medical Systems, Inc. : November 2, 2016 Nov 02 2016
Merit Medical to Present at Four Conferences in November Nov 01 2016
Merit Medical Systems, Inc. :MMSI-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016 Oct 31 2016
Edited Transcript of MMSI earnings conference call or presentation 26-Oct-16 9:00pm GMT Oct 26 2016
Merit Medical beats 3Q profit forecasts Oct 26 2016
Merit Medical beats 3Q profit forecasts Oct 26 2016
MERIT MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Oct 26 2016
Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 Oct 26 2016
Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 Oct 26 2016
Q3 2016 Merit Medical Systems Inc Earnings Release - After Market Close Oct 26 2016
Medical Product Earnings to Watch on Oct 26: BSX, LH & More Oct 25 2016
What's in Store for Merit Medical (MMSI) in Q3 Earnings? Oct 25 2016
MERIT MEDICAL SYSTEMS INC Files SEC form 8-K, Other Events Oct 21 2016
Merit Medical Completes Enrollment in EVOLVE Study Oct 19 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)